Deal: Alceon Private Equity has completed an investment in SMS.

Value: Undisclosed.

Area: Finance, corporate.

Key players: The Johnson Winter & Slattery team was led by partner Andrew Williams and special counsel Aidan Douglas, supported by associates Katherine McNamara and Rebecca Proudman.

Partner David Beckett and special counsel Man Loi advised on the banking aspects of this transaction, partner Christine Ecob, senior associate Stanley Yu, and associate Rachel Cox advised on the IP/IT aspects, and partner Peter Trevaskis and associate Lucy Wang advised on the property aspects.

Deal significance: Established in 2010, Alceon Private Equity is a leading private equity firm.

Since its inception, the group has invested over $3.8 billion of capital for its high net worth, family office and institutional clients across real estate, private equity and listed equity.

“With this deal, the firm will make a move into ophthalmology and short stay medical services by investing in SMS, which is a roll-up of ophthalmology clinics and short stay hospitals in Australia,” a statement from JWS explained.

VIEW ALL

“The business was founded by Carl Adams, who previously led the creation of radiology business QScan for Quadrant Private Equity.”

Commenting further, lead partner Andrew Williams said: “This investment by Alceon will enable SMS to capitalise on opportunities within short stay hospitals and ophthalmology clinics, which is a relatively untapped opportunity in the market”.

“We are delighted to have supported Alceon in this strategic transaction, which is its third investment so far this year.”